Kishimoto Takashi Kei 4
4 · SELECTA BIOSCIENCES INC · Filed Jan 6, 2023
Insider Transaction Report
Form 4
Kishimoto Takashi Kei
Chief Scientific Officer
Transactions
- Sale
Common Stock
2023-01-05$1.13/sh−3,372$3,808→ 364,336 total - Sale
Common Stock
2023-01-05$1.11/sh−20$22→ 364,316 total - Sale
Common Stock
2023-01-04$1.13/sh−6,381$7,234→ 367,719 total - Sale
Common Stock
2023-01-04$1.15/sh−11$13→ 367,708 total
Footnotes (1)
- [F1]Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.